MON-491 Persistent Isolated Hypophosphatemia after Intravenous Ferric Carboxymaltose Infusion in a Patient with Total Gastrectomy

Introduction: Intravenous ferric carboxymaltose infusion has been reported by the FDA to cause hypophosphatemia in 2.1% of patients, with transient low phosphorus level (<2mg/dL) observed in 27% of patients. We present a case of persistent hypophosphatemia where intravenous iron appeared to be a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Endocr Soc
Autors principals: Bailey, Rosemary, Del Castillo, Ma. Dolores, Muppavarapu, Sangeetha, Siegel, Richard, Vercollone, Jeffrey
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2019
Matèries:
Bone and Mineral Metabolism
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6550829/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-MON-491
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars